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he mechanism by which v-Src disrupts connexin
(Cx)43 intercellular gap junctional communication
(GJC) is not clear. In this study, we determined that
Tyr247 (Y247) and the previously identiﬁed Tyr265 (Y265)
site of Cx43 were the primary phosphorylation targets for
activated Src in vitro. We established an in vivo experimen-
tal system by stably expressing v-Src and wild-type (wt)
Cx43, or Y247F, Y265F, or Y247F/Y265F Cx43 mutants in a
Cx43 knockout mouse cell line. Wt and mutant Cx43 lo-
calized to the plasma membrane in the absence or pres-
ence of v-Src. When coexpressed with v-Src, the Y247F,
T
 
Y265F, and Y247F/Y265F Cx43 mutants exhibited signiﬁ-
cantly reduced levels of tyrosine phosphorylation com-
pared with wt Cx43, indicating that Y247 and Y265 were
phosphorylation targets of v-Src in vivo. Most importantly,
GJC established by the Y247F, Y265F, and Y247F/Y265F
Cx43 mutants was resistant to disruption by v-Src. Further-
more, we did not ﬁnd evidence for a role for mitogen-acti-
vated protein kinase in mediating the disruption of GJC by
v-Src. We conclude that phosphorylation on Y247 and
Y265 of Cx43 is responsible for disrupting GJC in these
mammalian cells expressing v-Src.
 
Introduction
 
Gap junctions are plasma membrane channels between adja-
cent cells with diameters of 
 
 
 
1.5–4 nm (Unger et al.,
1999). Gap junctions allow the intercellular exchange of
molecules 
 
 
 
1 kD. Each gap junction channel is composed
of two hexamers of connexin (Cx)* molecules provided by
each of the adjacent cells. Connexins are a multigene family
of membrane-spanning proteins that are highly homologous
in their extracellular and transmembrane domains but are
more structurally diverse in the cytoplasmic loops and
COOH tails (Goodenough et al., 1996).
It has been hypothesized that the disruption of the gap
junctional channel contributes to the uncontrolled growth
of cancer (Trosko and Ruch, 1998), possibly by interfering
with the exchange of growth regulatory signals through gap
junction channels (Loewenstein, 1981). Earlier studies dem-
onstrated that concomitant with the disruption of gap junc-
tional communication (GJC) in v-Src transformed cells
unique phosphorylation occurred on tyrosine (Tyr or Y)
sites in Cx43, a major connexin family member (Crow et al.,
1990; Filson et al., 1990). Later investigations showed that
Cx43 expressed in Sf-9 insect cells contained phosphoty-
rosine (pTyr) when coexpressed with v-Src but had no pTyr
content in the absence of v-Src (Loo et al., 1995). Impor-
tantly, purified activated Src phosphorylated Cx43 on tyro-
sine in vitro (Loo et al., 1995). These data suggested that the
phosphorylation of Cx43 on tyrosine was the result of a di-
rect kinase–substrate interaction between v-Src and Cx43.
Furthermore, confocal microscopy studies of Rat-1 v-Src fi-
broblasts suggested that v-Src and Cx43 partially colocalized
in regions of the plasma membrane (Loo et al., 1999).
Moreover, Cx43 coimmunoprecipitated with v-Src in in
vivo studies (Kanemitsu et al., 1997; Loo et al., 1999).
Taken together, these results suggested that v-Src interacts
with Cx43 directly in vivo.
Because the SH2 and SH3 domains of v-Src mediate its in-
teractions with substrate proteins (Brown and Cooper, 1996),
the role that these domains play in the interaction of v-Src
with Cx43 was investigated (Kanemitsu et al., 1997). This
study showed that mutation of the proline-rich motif located
 
at P
 
274
 
-P
 
284
 
 of Cx43 but not the motif at P
 
253
 
-P
 
256 
 
decreased
both the binding of Cx43 to v-Src and tyrosine phosphoryla-
tion of Cx43 in vitro. In addition, mutating Y265 of Cx43 to
phenylalanine (Phe or F) but not Y247 or Y267 greatly re-
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duced binding to v-Src and tyrosine phosphorylation of
Cx43, indicating that phosphorylation of the Y265 site was
important for the interaction of Cx43 with v-Src in vivo
(Kanemitsu et al., 1997). Thus, the SH3 and SH2 domains of
v-Src appear to mediate the interaction with Cx43, and this
may promote the direct phosphorylation of Cx43 on tyrosine.
Two studies using the 
 
Xenopus
 
 oocyte expression system
investigated how phosphorylation of Cx43 at specific tyro-
sine sites by v-Src affected GJC. In the study of Swenson et
al. (1990), comicroinjection of 
 
cx43
 
 and 
 
v-src
 
 RNAs into 
 
Xe-
nopus
 
 oocytes demonstrated that the expression of v-Src
completely disrupted GJC established by the expression of
wild-type (wt) Cx43 in the oocytes. However, substituting a
nonphosphorylatable Phe residue at the Y265 site greatly re-
duced tyrosine phosphorylation on Cx43 and rendered the
Cx43 channels resistant to disruption by v-Src. These results
suggested that phosphorylation of Y265 in Cx43 by v-Src
was required for the disruption of GJC. The data strongly
supported the concept that v-Src mediated the disruption of
GJC via tyrosine phosphorylation of Cx43.
However, a more recent study using the same experimen-
tal expression system suggested that the v-Src–mediated clo-
sure of Cx43 channels was not attributed to the tyrosine
phosphorylation of Cx43 at Y265 but rather to serine phos-
phorylation in the COOH-terminal domain of Cx43 (Zhou
et al., 1999). In this second study, gap junction channels
were allowed to form by the injection of 
 
cx43
 
 cRNA into 
 
Xe-
nopus
 
 oocytes before the introduction of the 
 
v-src
 
 cRNA.
Neither the Y265F nor the Y247F Cx43 mutant was found
to be resistant to the disruption of GJC induced by v-Src. In
addition, the use of inhibitors to block the activation of mi-
togen-activated protein (MAP) kinase and expression of
MAP kinase serine site Cx43 mutants provided results that
implicated the MAP kinase pathway and serine phosphory-
lation of Cx43 in the v-Src–mediated disruption of GJC.
However, the effects of these Cx43 mutations and inhibitors
of the MAP kinase pathway on Cx43 phosphorylation were
not examined in this study.
In the present study, a mammalian cell system was estab-
lished to express wt or phosphorylation site mutants of Cx43
in the absence or presence of v-Src. We observed that the
disruption of GJC by v-Src was inhibited by substituting
Phe for Tyr at the Y247 and Y265 sites of Cx43 but was not
disrupted by blocking the MAP kinase pathway. This inabil-
Figure 1. Analysis of the phosphoryla-
tion of GST–Cx43CT by activated Src in 
vitro. (A) Amino acid sequence of two 
predicted tryptic peptides of Cx43CT 
(S244-K258 and Y265-K287) that contain the 
putative pTyr sites (Y247 and Y265) in 
the phosphorylated GST–Cx43CT fusion 
protein. Cx43CT fused to GST begins at 
V236 in the cytoplasmic tail of Cx43. 
The amino acids deleted in the Cx43CT 
deletion mutant are bracketed 
(P253LSP256). (B) Two-dimensional phos-
photryptic peptide analysis of GST 
fusion proteins with wt or the Cx43CT 
deletion mutation phosphorylated by 
activated Src. Phosphotryptic peptides 
were resolved by electrophoresis 
(dimension 1) followed by ascending 
chromatography (dimension 2). Major 
phosphotryptic peptides are numbered. 
(C) Phosphoamino acid content of wt or 
site-directed mutant GST–Cx43CT phos-
phorylated by activated Src. Equal 
amounts of the GST–Cx43CT substrates 
were phosphorylated by Src, acid-hydro-
lyzed, and separated by electrophoresis 
at pH 1.9 (dimension 1) followed by 
electrophoresis at pH 3.5 (dimension 2). 
The migration positions of the unlabeled 
pSer, pThr, and pTyr standards are indi-
cated. (D) Phosphotryptic peptide maps 
of wt and mutant GST–Cx43CT phos-
phorylated by activated Src. Resolved 
peptides were from one type of GST–
Cx43CT or a mixture of wt and the 
Y265F GST–Cx43CT mutant. Peptides 
are numbered as in B. 
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ity of v-Src to disrupt GJC in cells coexpressing the Cx43
mutants was accompanied by a reduction in tyrosine phos-
phorylation of Cx43. Thus, the results presented here indi-
cate that tyrosine phosphorylation of Cx43 represents a ma-
jor mechanism that underlies the disruption of GJC in these
mammalian cells expressing the v-Src oncoprotein. These
data support a model for the processive phosphorylation of
Cx43 by v-Src in vivo.
 
Results
 
Phosphorylation of Y247 and Y265 of Cx43CT by 
activated Src in vitro
 
Site-directed mutagenesis indicated that Y265 of Cx43 was a
primary Tyr site targeted by v-Src upon coexpression of
these proteins in 
 
Xenopus
 
 oocytes (Swenson et al., 1990).
This study did not attempt to identify possible additional ty-
rosine phosphorylation sites in Cx43. However, the observa-
tion of two distinct pTyr-containing phosphopeptides of
Cx43 in Rat-1 v-Src cells suggested that v-Src may phos-
phorylate Cx43 at an additional Tyr site(s) (Kurata and Lau,
1994). Because Y247, like Y265, is in a tyrosine kinase phos-
phorylation consensus sequence, we examined whether Y247
is another site targeted by activated Src. Glutathione 
 
S
 
-trans-
ferase (GST) fusion proteins with wt Cx43 COOH-terminal
tail (CT) or a deletion mutant that lacks residues P
 
253
 
-P
 
256
 
(Kanemitsu et al., 1997) of Cx43CT were phosphorylated
by activated Src in vitro and subjected to two-dimensional
phosphotryptic peptide analysis. Since the P
 
253
 
-P
 
256
 
 deletion
is located in tryptic peptide S
 
244
 
-K
 
258
 
 (Fig. 1 A), it was ex-
pected to alter the migration of this peptide. Phosphopeptide
4 detected in the map of phosphorylated wt GST–Cx43CT
disappeared from the map of the phosphorylated deletion
mutant GST–Cx43CT with the concomitant appearance of
a slower migrating phosphopeptide, labeled 4
 
 
 
 (Fig. 1 B).
Because this was the only difference observed in the peptide
maps, we concluded that peptide 4 must be peptide S
 
244
 
-
K
 
258
 
, whereas peptide 4
 
 
 
 represents the same peptide with
the P
 
253
 
-P
 
256
 
 deletion. This conclusion was supported by a
calculation of the relative peptide mobilities, which indicated
that the peptide from the deletion mutant would migrate
more slowly than the wt peptide in the second chromato-
graphic dimension (Boyle et al., 1991). Because the deletion
localizes in a phosphopeptide that contains a single Tyr site
(Y247) (Fig. 1 A) and Src phosphorylates GST–Cx43CT
only on Tyr (see below), Y247 represents another Tyr site in
Cx43 that is phosphorylated by Src in vitro.
To further examine the Src-mediated phosphorylation of
Cx43 at Y247 and Y265, we generated GST–Cx43CT with
a Y247F, Y265F, or Y247F/Y265F double Cx43 muta-
tion. Phosphoamino acid analysis established that all GST–
Cx43CT substrates phosphorylated by Src contained only
pTyr (Fig. 1 C). However, data obtained in one experiment
with equal amounts of GST–Cx43CT fusion proteins indi-
cated that the Y247F and Y265F Cx43 mutants appeared to
have less pTyr than wt Cx43 (86 and 63%, respectively). The
Y247F/Y265F double mutant had an even lower level of pTyr
than the single mutants (26% of wt), suggesting that both the
Y247 and Y265 sites were required for full phosphorylation of
wt Cx43CT by Src in vitro. The detection of pTyr in the
 
Y247F/Y265F mutant suggested the presence of an additional
pTyr site in wt Cx43CT induced by Src in vitro.
Two-dimensional phosphotryptic peptide mapping re-
vealed that wt Cx43CT phosphorylated by Src in vitro con-
tained three major phosphopeptides: 1, 4, and 5 (Fig. 1 D).
Phosphopeptide 4 disappeared in the Y247F and Y247F/
Y265F Cx43CT point mutants, indicating that it contained
Y247 (Fig. 1 D). These data confirmed the previous conclu-
sion obtained with the GST–Cx43CT P
 
253
 
-P
 
256
 
 deletion mu-
tant (Fig. 1 B) that Src phosphorylated Cx43CT at Y247 in
vitro. Compared with wt Cx43CT, phosphorylation of pep-
tide 1 was reduced in the Y265F Cx43 mutant. This peptide
appeared to migrate faster in the second dimension in the
Y265F and double Cx43 mutants, possibly due to the substi-
tution of Tyr by the more hydrophobic Phe residue (Fig. 1 D,
labeled 1
 
 
 
). Analysis of a mixture of wt and Y265F Cx43CT
samples confirmed this difference in migration. Taken to-
gether, these data suggested that phosphopeptide 1 contained
the Y265 site (Fig. 1 D). Interestingly, phosphopeptide 5 still
appeared in the double Cx43CT mutant, supporting the sug-
gestion of another pTyr site in Cx43CT induced by Src in
vitro. However, significant phosphorylation at an additional
tyrosine site was not observed in full-length Cx43 phosphory-
lated in vivo (see Discussion).
 
Expression of Cx43 and v-Src in the different cell clones
 
Wt and mutant Cx43 were expressed in Cx43 knockout
(KO) cells and clones with similar levels of GJC were in-
fected with the v-Src retrovirus. To characterize the expres-
sion of v-Src in the Cx43 reexpressing cells, an in vitro
kinase assay was performed on the morphologically trans-
formed cell clones infected by pL
 
vsrc
 
SH. Equal amounts of
antibody were used to immunoprecipitate v-Src from equal
amounts of cell lysate, followed by an in vitro kinase assay of
immunoprecipitated v-Src. As expected, the negative control
Figure 2. Levels of v-Src kinase activity and Cx43 in the cell 
clones. (A) In vitro v-Src protein kinase activities. The same amounts 
of anti-Src TBR serum 6-1-4 were reacted with equal amounts of 
cell lysate from each clone. The ability of v-Src to phosphorylate the 
heavy chain of IgG in an immune complex kinase assay was exam-
ined. Clone wtC1 infected by the pLXSH vector alone served as a 
negative control. Asterisks indicate the clones chosen for further 
biochemical analysis. (B) Expression of Cx43. 40  g of whole cell 
lysates was resolved by SDS-PAGE and electrotransferred to Immo-
bilon-P membranes. 
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wtC1 cells showed no v-Src kinase activity (Fig. 2 A, first
lane). All of the other clones exhibited v-Src kinase activity
with some differences in the levels of activity. One clone (in-
dicated by an asterisk) from each set of infections by wt or
mutant pBABE-
 
cx43
 
 and pL
 
vsrc
 
SH retroviruses with the
most similar levels of v-Src kinase activity was chosen for
further biochemical analysis. The selected clones were wtS2,
247FS2, 265FS1, and dbS2. The wtC1 clone was used as a
negative control.
Immunoblotting analysis was performed to measure the
expression of Cx43 in the selected clones (Fig. 2 B). 40 
 
 
 
g
of whole cell lysate was loaded for each sample. Approxi-
mately equal levels of Cx43 were detected in all cell clones,
indicating that the antibody recognized both the wt and the
mutated Cx43 proteins and that the substitution of the Phe
residue for Tyr did not affect the expression of Cx43 (Fig. 2
B). The antibody recognized the most abundant nonphos-
phorylated isoform of Cx43, and in some samples a slower
migrating phosphorylated isoform was also detected.
 
Localization of wt and mutant Cx43 in
v-Src–expressing cells
 
Immunofluorescence microscopy of Cx43 was performed to
determine whether the conservative substitution of Phe at
the Y247 and/or Y265 site or the expression of v-Src in the
 
cells disrupted the assembly or maintenance of Cx43 gap
junction plaques. Cx43 gap junction plaques were detected
in the plasma membranes of wtC1 cells and in the 247FC1,
265FC1, and dbC1 cells (Fig. 3, top, arrowheads). Wt and
mutant Cx43 were also localized to the plasma membrane of
the clones coexpressing v-Src (Fig. 3, bottom panel). The
v-Src–expressing cells were more rounded than the non-Src
cells, and some gap junctions were not clearly in focus in a
particular focal plane. All of the clones also exhibited Cx43-
specific reactions in intracellular locations. These results in-
dicated that the assembly of the Cx43 mutants into gap
junction plaques was not largely disrupted by the introduc-
tion of phosphorylation site mutations or by the coexpres-
sion of v-Src. Thus, wt and mutant Cx43 have the potential
to establish functionally active gap junction channels, and
no gross loss of gap junctional plaques was apparent in our
cells stably expressing v-Src.
 
Phosphorylation of wt and mutant Cx43 in
v-Src–expressing cells
 
To examine the phosphorylation of Cx43 in cells expressing
Cx43 and v-Src, the cells were metabolically labeled with
 
32
 
P
 
i
 
, and Cx43 was immunoprecipitated from the cell lysates
with equal amounts of antibody (Fig. 4 A). Phosphorylated
Cx43 from the different clones was present as isoforms
Figure 3. Localization of wt or mutant Cx43 to the plasma membrane. Top, cells lacking v-Src; bottom, cells expressing v-Src. Cells were 
grown to subconfluence on coverslips before being fixed and permeabilized. Cx43CT368 antiserum was used to detect Cx43. Arrowheads
indicate the positions of some Cx43 gap junction plaques. 
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migrating with different mobilities as observed previously
(Crow et al., 1990; Filson et al., 1990; Laird et al., 1995).
More importantly, the levels of phosphorylated Cx43 in the
v-Src–expressing clones were markedly increased compared
with the wtC1 cells that lacked v-Src. Given that the levels
of Cx43 were similar among the cell clones (Fig. 2 B), these
data suggested that v-Src upregulated the phosphorylation of
Cx43, consistent with previous reports (Crow et al., 1990;
Filson et al., 1990; Goldberg and Lau, 1993).
Phosphoamino acid analysis demonstrated that Cx43 im-
munoprecipitated from 
 
32
 
P-labeled wtC1 cells, which did
not express v-Src, contained only phosphoserine (pSer) (Fig.
4 B). Wt Cx43 from the v-Src expressing clone wtS2 con-
tained pSer and pTyr (Fig. 4 B), suggesting that v-Src tar-
geted wt Cx43 in these cells. However, the levels of pTyr ap-
peared to be reduced in the Y265F, and the double Cx43
mutants coexpressed with v-Src. Finally, the Y247F Cx43
mutant appeared to contain more pTyr than the Y265F
Cx43 mutant.
Because it is difficult to obtain quantitative data from
phosphoamino acid analysis, immunoblotting analysis using
a pTyr antibody was performed to quantify the levels of
pTyr in Cx43 isolated from the various clones. Cx43 was
immunoprecipitated from lysates of the different clones us-
ing the same amount of antibody under conditions of anti-
gen excess. As expected, Cx43 from wtC1 cells did not con-
tain pTyr, whereas Cx43 from wtS2 cells expressing v-Src
contained pTyr (Fig. 4 C). In cells coexpressing the Y247F
Cx43 mutant and v-Src, a reduced but significant amount of
pTyr of Cx43 was observed (
 
 
 
57% of wt Cx43). However,
compared with wt Cx43 the levels of pTyr in the Y265F and
the double Cx43, mutants coexpressed with v-Src were
greatly reduced to 
 
 
 
10% and 2%, respectively (Fig. 4 C).
These results indicated that v-Src phosphorylated wt Cx43
at both the Y265 and Y247 sites in vivo, confirming the
identification of these sites as Src targets in our in vitro studies.
To further characterize Cx43 phosphorylation in vivo, we
employed two-dimensional phosphotryptic peptide analysis.
The peptide maps obtained were complex due to potential
phosphorylation on multiple serine and tyrosine sites (Fig.
5). Although the maps did not provide additional insight
into the mechanism(s) of v-Src–induced Cx43 phosphoryla-
tion, some differences were apparent, which were consistent
with the mutations introduced in Cx43. Three phosphopep-
tides migrated in the region of peptide 4 (Fig. 1 D) and were
assigned tentatively to the Y247 peptide (Fig. 1D, boxed
area). These peptides migrated similarly in the Y247F and
Y247F/Y265F Cx43 mutants and had a different arrange-
ment in the wt and Y265F proteins. This difference in mi-
gration is consistent with the loss of a tyrosine phosphoryla-
tion site and the substitution of the more hydrophobic Phe
residue at the Y247 site in the Y247F and Y247F/Y265F
mutants. Phosphopeptides ascribed to the Y265 peptide are
also boxed. The migration patterns here are more similar in
the Y265F and Y247F/Y265F mutants, which have a Phe
substitution on the Y265 peptide. These patterns differ from
those obtained with the wt and Y247F Cx43 proteins as ob-
served previously in our in vitro studies (Fig. 1 D).
 
GJC in cells expressing wt and mutant Cx43 and v-Src
 
To determine the functional significance of phosphorylation
at the Y247 or Y265 site in Cx43, GJC was measured in the
clones by the transfer of Lucifer yellow dye 1 min after injec-
tion of the dye into the parental cells. To address the possi-
bility of clonal variability, GJC was determined for two in-
dependently isolated clones for each experimental group. In
the absence of v-Src, the substitution of Phe for Tyr at resi-
dues 247 or 265 did not disrupt the ability of Cx43 to estab-
lish functional gap junction channels (Table I). However,
the expression of v-Src induced a dramatic disruption of dye
transfer (
 
 
 
14-fold reduction in degree of coupling and 
 
 
 
5-
fold change in the incidence of coupling) in cell clones coex-
Figure 4. Phosphorylation of wt or mutant Cx43 in v-Src–express-
ing cells. (A) Immunoprecipitation of Cx43. Confluent cells were 
metabolically labeled with 
32Pi. Cx43 was immunoprecipitated from 
cell lysates with Cx43CT368 antiserum under conditions of antigen 
excess. The positions of multiple isoforms of phosphorylated Cx43 
are shown by brackets. (B) Phosphoamino acid content of Cx43 im-
munoprecipitated from the cell clones. Immunoprecipitated 
32P-
labeled Cx43 was acid hydrolyzed and separated in two dimensions 
as indicated. (C) pTyr content of Cx43 from the cell clones. Cells 
were grown to confluence and the same amount of Cx43CT368 
antiserum was used to immunoprecipitate Cx43 from cell lysates 
under conditions of antigen excess. The pTyr content of Cx43 was 
detected with a pTyr antibody (top). Quantitation of pTyr in Cx43 is 
shown in the bottom part of the figure. The average relative 
amounts of pTyr of Cx43 were obtained from scans of the Cx43 
images of the top and from a second experiment. The levels of pTyr 
of Cx43 from wtC1 and wtS2 were normalized to 0 and 100%, 
respectively. 
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pressing wt Cx43 compared with cell clones expressing wt
Cx43 without v-Src (Table I,
 
 P 
 
 
 
 0.01). This observation
was consistent with previous results that showed that GJC
was disrupted in cells containing the v-Src oncoprotein (At-
kinson et al., 1981; Crow et al., 1990; Filson et al., 1990;
Kurata and Lau, 1994). Importantly, dye transfer was un-
perturbed (
 
P
 
 
 
 
 
 0.05) by the expression of v-Src in cells ex-
pressing the Y247F Cx43 mutant (247FS1 and 247FS2) or
the double Cx43 mutant (dbS1 and dbS2). In addition, cells
expressing v-Src together with the Y265F Cx43 mutant
(265FS1 and 265FS2) exhibited high levels of GJC. Thus,
v-Src either failed to disrupt, or induced a low level (
 
 
 
20%)
of disruption of, GJC in the cells coexpressing the Y247F
and/or Y265F Cx43 mutants. Furthermore, the incidence of
gap junctional coupling in cell clones expressing the Cx43
mutants in the presence or absence of v-Src was 100% in
nearly all cases (Table I) in contrast to the cells expressing wt
Cx43 and v-Src (18–19% coupled). The dramatic reduction
of GJC in the cells expressing wt Cx43 with v-Src but not in
the cells expressing Cx43 tyrosine mutants and v-Src, is also
illustrated by fluorescent images captured at 4–6 min after
the microinjection of single cells (Fig. 6). These dye transfer
results obtained by microinjection of single cells were sub-
stantiated by the scrape-loading technique (unpublished
data). The observation that the Y247F and Y265F substitu-
tions rendered Cx43 resistant to the disruption of GJC by
v-Src strongly suggested that phosphorylation of Cx43 at
these specific tyrosine sites represents a key mechanism un-
derlying v-Src’s ability to disrupt GJC in these cells.
 
Role of increased serine phosphorylation of Cx43 
induced by v-Src
 
In this study, we demonstrated that phosphorylation of
Cx43 at Y247 and Y265 was primarily responsible for the
disruption of GJC by v-Src. However, Zhou et al. (1999) re-
ported that the ability of v-Src to induce cell uncoupling was
attenuated by treating cells with the MAP kinase kinase
(MEK) inhibitor, PD98059, to block MAP kinase activa-
tion. This suggested that serine phosphorylation of Cx43,
perhaps by activated MAP kinase, may have contributed to
the disruption of GJC by v-Src. We also used the MEK in-
hibitor to examine the possibility that serine phosphoryla-
tion of Cx43 might be involved in the downregulation of
GJC by v-Src in mammalian cells.
WtS2 cells were treated with 100 
 
 
 
M MEK inhibitor for
1 h. Interestingly, this treatment failed to restore GJC. Un-
treated wtS2 cells communicated to an average of 1.0 neigh-
boring cell compared with an average of 0.9 adjacent cells af-
ter treatment (Fig. 7, lanes 3 and 4). The wtC1 control cells,
expressing wt Cx43 without v-Src, communicated to an av-
erage of 13.1 adjacent cells (Fig. 7, lane 1). To confirm that
the MEK inhibitor treatment inhibited MAP kinase activa-
tion, the levels of active MAP kinase were determined from
equivalent amounts of whole cell lysate by immunoblotting
with an antibody recognizing the phosphorylated, activated
form of MAP kinase. As a positive control, wtC1 cells
treated with EGF showed increased levels of active MAP ki-
nase compared with the untreated cells (Fig. 7, lanes 2 and
1, respectively). Activated MAP kinase was detected in the
wtS2 cells treated with DMSO alone; however, treatment of
these cells with the MEK inhibitor reduced activated MAP
kinase to 
 
 
 
5% of the untreated wtS2 cells. Fig. 7, lane 5,
represents a single plate of wtS2 cells that communicated to
an average of 0.5 neighboring cells after treatment with the
MEK inhibitor. Immunoblotting the cell lysate from this
single plate demonstrated that MAP kinase was reduced
Figure 5. Two-dimensional phosphotryptic peptide 
analysis of wt and mutant forms of Cx43 isolated 
from cells metabolically labeled with 
32Pi. Phospho-
tryptic peptides were resolved by electrophoresis (di-
mension 1) followed by ascending chromatography 
(dimension 2). Boxes show phosphopeptides tenta-
tively ascribed to the Y247 or the Y265 containing 
peptides.
Figure 6. Fluorescent images from microinjection of the v-Src–
expressing cell clones. Fluorescent images were captured and 
recorded at 4–6 min after microinjections of single cells with Lucifer 
yellow dye. 
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markedly to 
 
 
 
2% of the untreated wtS2 cells. In addition,
we determined that the wtS2 cells treated with 100 
 
 
 
M
MEK inhibitor for 4 h communicated to an average of
1.0 
 
 
 
 0.2 (
 
n
 
 
 
 
 
 20) neighboring cells and also showed sig-
nificantly reduced levels of activated MAP kinase (unpub-
lished data). Taken together, these observations strongly
suggested that activated MAP kinase did not play a role in
the disruption of GJC induced by v-Src in our cells.
 
Discussion
 
We have been interested in identifying molecular mecha-
nisms that regulate Cx43-mediated GJC and how GJC is
regulated by tyrosine protein kinases such as the EGF recep-
tor and v-Src. The regulation of GJC is of particular interest
due to the putative role of connexins in the regulation of cell
growth. The expression of v-Src in mammalian cells results
in cell transformation, tyrosine phosphorylation on numer-
ous proteins, and a dramatic reduction in GJC. In this
study, both in vitro and in vivo experimental approaches
were employed to study the molecular mechanisms responsi-
ble for the disruption of GJC by v-Src. Fusion proteins
containing wt or mutant Cx43CT were phosphorylated in
vitro by activated Src to characterize phosphorylation of
Cx43CT. More importantly, wt Cx43 and Y247F, Y265F,
and Y247F/Y265F Cx43 mutants were expressed in a Cx43
KO cell line and cell clones that stably expressed membrane-
localized Cx43, and established GJC were selected for fur-
ther study. These cells were infected with a retroviral con-
struct containing the 
 
v-src
 
 gene and the effects of v-Src on
Cx43 membrane localization, protein phosphorylation, and
GJC were examined.
 
Identification of Y265 and Y247 as Cx43 sites targeted 
by v-Src
 
The results presented in this study not only confirmed previ-
ous reports that Y265 of Cx43 is a primary site phosphory-
 
lated by v-Src (Swenson et al., 1990; Kanemitsu et al., 1997)
but also identified Y247 as an additional major site of Cx43
targeted by activated Src in vitro and in intact cells. These
conclusions were based upon several observations. First, in an
earlier study we found evidence for a second pTyr site on
Cx43 isolated from Rat-1 v-Src cells (Kurata and Lau, 1994).
A potential consensus tyrosine target site for Src was identified
at Y247 of Cx43. In the present study, phosphorylation of a
mutant Cx43CT lacking amino acids P
 
253
 
-P
 
256
 
 resulted in a
clear shift in the migration of a major phosphotryptic peptide
(peptide 4, S
 
244
 
–K
 
258
 
), which contains a single tyrosine resi-
due, Y247 (Fig. 1, A and B). Since activated Src phosphory-
lated GST–Cx43CT only on tyrosine (Fig. 1 C), these data
strongly indicated that Y247 was a major site phosphorylated
by activated Src in vitro. Second, Cx43CT phosphorylated by
activated Src showed reduced amounts of pTyr (Fig. 1 C) and
the complete loss or a shift in the migration of specific pep-
tides (Fig. 1 D) when Y247 and/or Y265 were mutated to
nonphosphorylatable Phe. These data supported the concept
that activated Src phosphorylated Y247 and Y265 in vitro.
Third and most significantly, the Cx43 double mutant co-
expressed with v-Src in mammalian cells showed a marked
loss of pTyr (
 
 
 
50-fold) compared with wt Cx43 (Fig. 4 C),
suggesting that blocking phosphorylation at the Y247 and
Y265 sites eliminated almost all tyrosine phosphorylation on
Cx43 in mammalian cells coexpressing v-Src. This suggested
that very little tyrosine phosphorylation occurred at other ty-
rosine sites in Cx43 in vivo, at least in the absence of phos-
phorylation at the Y265 site. The Y247F Cx43 mutant ex-
hibited a significant amount of pTyr (Fig. 4 B), which
represented about 57% of that of wt Cx43 (Fig. 4 C). Phos-
phorylated Y265 presumably accounted for most of the pTyr
in this mutant. Interestingly, the pTyr content of the Y265F
Cx43 mutant was also significantly reduced to about 10% of
that of wt Cx43 (Fig. 4 C). This suggested that the phos-
phorylation of Y247 by v-Src was largely dependent upon the
prior or concomitant phosphorylation of the Y265 site.
 
Table I. 
 
Measurement of GJC in cell clones containing wt or mutant 
 
cx43
 
 genes with or without the 
 
v-src
 
 gene
Cell clone wt or mutant 
 
cx43 v-src
 
GJC Incidence of coupling
 
%
 
wtC1 wt
 
 
 
13.1 
 
 
 
 0.5 (24) 100
wtC2 wt
 
 
 
13.9 
 
 
 
 0.9 (23) 100
wtS1 wt
 
 
 
1.3 
 
 
 
 0.2 (53) 19
wtS2 wt
 
 
 
1.0 
 
 
 
 0.2 (45) 18
247FC1 Y247F
 
 
 
10.3 
 
  0.5 (15) 100
247FS1 Y247F   10.4   0.8 (45) 98
247FS2 Y247F   11.8   0.4 (43) 100
265FC1 Y265F   10.7   0.8 (17) 100
265FC2 Y265F   12.5   0.5 (32) 100
265FS1 Y265F   9.0   0.6 (39) 97
265FS2 Y265F   8.6   0.6 (31) 100
dbC1 Y247F/Y265F   11.3   0.6 (28) 100
dbC2 Y247F/Y265F   9.8   0.6 (42) 95
dbS1 Y247F/Y265F   12.7   0.7 (39) 100
dbS2 Y247F/Y265F   9.6   0.6 (37) 100
The nomenclature of the cell clones, the different cx43 genes, and whether the v-src gene is expressed are indicated. GJC values were measured by transfer
of Lucifer yellow dye following the microinjection of single cells. The number of adjacent cells that become fluorescent (  SEM) was counted 1 min after
microinjection. The total numbers of cells injected for each clone are indicated in parentheses. The percentages of injected cells that transferred dye to more
than one neighboring cell are recorded as the incidence of coupling. Except for the wt cells (P   0.01), there was no significant difference in the values of
GJC between the v-Src containing clones and the non–v-Src–containing clones (P   0.05 in a two-tailed Student’s t test).822 The Journal of Cell Biology | Volume 154, 2001
The role of pTyr sites in Cx43 in the disruption of GJC 
induced by v-Src
Previous studies have indicated a strong correlation between
the disruption of GJC and the phosphorylation of Cx43 on
tyrosine in cells expressing v-Src (Crow et al., 1990; Filson
et al., 1990). Moreover, the specific phosphorylation of
Y265 in Cx43 was implicated in the ability of v-Src to dis-
rupt gap junctional conductance in Xenopus oocytes (Swen-
son et al., 1990). The experimental system developed in this
study enabled us to not only directly determine whether
phosphorylation at Y247 and/or Y265 of Cx43 was respon-
sible for the downregulation of GJC by v-Src but also pro-
vided novel insights into the relative contributions of these
two sites to this effect.
These experiments were possible because the Y247F and
Y265F mutations did not appear to interfere with the local-
ization of Cx43 to the plasma membrane as determined by
immunofluorescence microscopy (Fig. 3). The Cx43 mu-
tants established functional gap junctions that transferred
dye at levels similar to the wt Cx43 channels (Table I).
However, we found that gap junctions established by the
double Cx43 mutant were completely resistant to v-Src in
these mammalian cells (Table I). This functional difference
correlated with a marked reduction in the pTyr content of
the mutant Cx43 (Fig. 4 C). The persistence of GJC in the
double Cx43 mutant clones was not due to lower levels of
v-Src tyrosine kinase activity. In fact, clone dbS1 expressing
the double Cx43 mutant had the highest level of v-Src ki-
nase activity of the clones examined (Fig. 2 A), yet it did not
show inhibition of GJC (Table I and Fig. 6). Thus, it was
likely that the substitution of Phe for Tyr at the Y247 and
Y265 sites of Cx43 rendered the cells resistant to the disrup-
tion of GJC by v-Src. Combined with the data that v-Src in-
duced little or no disruption of GJC in cells coexpressing the
Y247F or Y265F Cx43 mutants, these observations strongly
suggested that v-Src disrupts Cx43-mediated GJC through
phosphorylation at the Y247 and Y265 sites.
Measurement of dye transfer in cells coexpressing the single
tyrosine site mutants and v-Src offered intriguing insights into
the possible differential roles for these sites in the regulation of
Cx43 function. The level of GJC for the cells expressing the
Y247F Cx43 mutant was unperturbed by v-Src (Table I),
even though these cells contained a significant level of pTyr
on Cx43 ( 57% of wt Cx43) (Fig. 4 C). This phosphoryla-
tion presumably occurred primarily at the Y265 site, since the
double Cx43 mutant lost  98% of the pTyr content as com-
pared with wt Cx43. Yet, phosphorylation at the Y265 site
alone in the Y247F Cx43 mutant was not sufficient to disrupt
GJC. The markedly reduced pTyr content ( 10%) of the
Y265F Cx43 mutant suggested that phosphorylation of Y265
by v-Src may be required for efficient phosphorylation of
Cx43 at the Y247 site in vivo. This result differs from that ob-
tained in our in vitro studies with the GST–Cx43CT fusion
protein and may be due to the differences in the protein sub-
strates (GST–Cx43CT versus full-length Cx43) and the lack
of competing substrates for v-Src in the in vitro system. Nev-
ertheless, the data obtained from our in vivo studies suggested
that phosphorylation of Y247 rather than Y265 is the critical
molecular event that is directly responsible for the disruption
of gap junctions by v-Src. Taken together with the binding
studies of Cx43 and v-Src (Kanemitsu et al., 1997), these data
suggested that phosphorylation of Y265 in wt Cx43 may be
essential to stabilize the interaction of these two proteins and
to permit efficient phosphorylation of Y247. The subsequent
phosphorylation at Y247 may be directly involved in the ac-
tual closure of gap junctions.
This hypothesis is consistent with the observation that the
Y265F Cx43 mutant expressed in either Xenopus oocytes
(Swenson et al., 1990) or mammalian fibroblasts (Table I)
was largely resistant to the disruption of GJC by v-Src. Ty-
rosine phosphorylation of this mutant was reduced in the
Xenopus oocytes, but the extent of reduction was not quanti-
fied. We found that phosphorylation of the Y265F Cx43
mutant on tyrosine in fibroblasts was reduced markedly to
 10% of the level of wt Cx43 (Fig. 4 C). This indicated
that phosphorylation of the wt Y247 site by v-Src was largely
blocked in the Y265F Cx43 mutant. Thus, the resistance of
the Y265F Cx43 mutant to v-Src may result from the ineffi-
cient phosphorylation of Y247 because of reduced stability
of the interaction of Cx43 and v-Src in the absence of a
phosphorylated Y265 residue.
Our data differ from the results of a second study in the
Xenopus expression system (Zhou et al., 1999), which re-
ported that GJC established by either a Y265F or Y247F
Cx43 mutant was sensitive to disruption by v-Src. The au-
thors concluded that Tyr phosphorylation was not involved
in the disruption of GJC in the v-Src–expressing oocytes.
Figure 7. The role of MAP kinase in the disruption of GJC by
v-Src. Cells were untreated or treated with EGF or the MEK inhibitor 
before being lysed. The same amount of whole cell lysate was 
loaded for each sample. Activated MAP kinase was detected with
an antibody recognizing phosphorylated MAP kinase. Lane 1, 
untreated wtC1; lane 2, wtC1 treated with 100 ng/ml EGF for 2 min; 
lane 3, untreated wtS2; and lanes 4 and 5, duplicate plates of wtS2 
treated with 100  M MEK inhibitor for 1 h. The same membrane 
used to detect active MAP kinase was stripped and reprobed with an 
antibody recognizing all isoforms of p42 MAP kinase. The ratios of 
active MAP kinase to total MAP kinase were determined and nor-
malized to the untreated wtS2 cells set as 100%. Average GJC 
values obtained from multiple plates are reported for lanes 1, 3, and 
4, and the GJC value from a single plate that was also used to mea-
sure the level of activated MAP kinase is shown for lane 5. The num-
ber of injections contributing to the determination of GJC is shown 
in brackets. Active MAP kinase was reduced to 5 and 2% of the 
starting level by the 1 h treatment with MEK inhibitor as shown in 
lanes 4 and 5, respectively.Phosphorylation of Cx43 by Src | Lin et al. 823
The fundamental reason(s) for these experimental differ-
ences is unclear. However, it is important to note that our
data strongly corroborate and extend the original work of
Swenson et al. (1990), which was performed in the Xenopus
oocyte system and was the first demonstration of the re-
quirement for phosphorylation of Tyr265 in v-Src’s ability
to disrupt GJC. In addition, our results are in agreement
with two recently published papers focused on the effects of
kinase-activated c-Src on the Y265F Cx43 mutant (Giep-
mans et al., 2001; Toyofuku et al., 2001). These latter stud-
ies demonstrated that activated c-Src not only interacted
with Cx43 but also phosphorylated Cx43 at Y265 in mam-
malian cells and significantly reduced GJC. Thus, four inde-
pendent reports consistently indicated the importance of ty-
rosine phosphorylation in Src’s effects on Cx43 function.
This conclusion is also consistent with Src’s ability to inter-
act directly with Cx43 in vivo (Kanemitsu et al., 1997; Loo
et al., 1999) and to phosphorylate Cx43 directly in in vitro
kinase reactions (Loo et al., 1995; Giepmans et al., 2001).
To explain the differences between their data and those of
Swenson et al. (1990) in the oocyte system, Zhou et al.
(1999) speculated that their experiments focused on the ef-
fects of v-Src on the gating of preestablished Cx43 channels.
The cRNA for v-src was injected  16 h after the injection of
the cRNA for Cx43 in their study, and they speculated that
the effects were not occurring through a nonspecific effect
on Cx43 biosynthesis or assembly as may have been the case
in Swenson et al. (1990). However, this suggestion was not
demonstrated experimentally. In the studies of Zhou et al.
(1999), the various Cx43 cRNAs were injected at levels from
0.5–8 ng/oocyte to obtain “comparable coupling levels,”
whereas the cRNA for v-Src remained constant at 7 ng/oo-
cyte. It is not clear whether there may have been differences
in the assembly or maintenance of the Cx43 channels that
were formed by the different Cx43 mutants in the oocyte
system. Thus, the fundamental difference between the re-
sults presented by Zhou et al. (1999) and Swenson et al.
(1990) was not clearly established. However, we did not de-
tect large differences in either the level or the plasma mem-
brane localization of wt or mutant Cx43 in the absence or
presence of v-Src expressed in our mammalian cells. Cx43
was localized to the plasma membrane in gap junctional
plaques in the v-Src–expressing cells (Fig. 3) and the levels of
Cx43 protein did not appear to be reduced on Western blots
(Fig. 2 B). Similar results demonstrating a lack of effect of
v-Src on Cx43 localization have been reported in previous
studies (Atkinson and Sheridan, 1985; Crow et al., 1990;
Loo et al., 1999). Zhou et al. (1999) also did not detect ob-
vious effects on the distribution of gap junction plaques in
the normal rat kidney (NRK) cells after the shift to the per-
missive temperature in the time examined.
Xenopus oocytes and mammalian cells clearly represent
two different expression systems. Differences between these
two experimental systems in terms of connexin expression
and channel formation have been observed previously. In
contrast to HeLa cells, the expression of rat Cx46 and the
formation of functional channels in oocytes required suffi-
cient extracellular Ca
2  to prevent hemichannels from open-
ing at the resting potential and depolarizing the cells (Paul et
al., 1991; Willecke and Haubrich, 1996). Moreover, murine
Cx31 formed functional channels in HeLa cells but not in
oocytes. It is also possible that posttranslational processing
and other modifications (i.e., phosphorylation) are substan-
tively different between the two expression systems (Wil-
lecke and Haubrich, 1996). In this study, the Cx43-defi-
cient fibroblast cell line was selected as the recipient cell for
mutant Cx43 because it normally expresses Cx43 and repre-
sents the cell type typically targeted by the Rous sarcoma vi-
rus harboring the src oncogene. The expression of noncondi-
tionally activated v-Src and Cx43 in fibroblasts occurs in a
constitutive fashion, unlike the transient expression of pro-
teins from microinjected RNAs in Xenopus oocytes. Thus,
the levels of Cx43 and v-Src, the v-Src kinase activity, and
the experimental temperature are unperturbed in this sys-
tem, unlike the experimental conditions in the Xenopus oo-
cyte and temperature-sensitive NRK cell systems employed
by Zhou et al. (1999).
MAP kinase is not involved in the disruption of GJC 
induced by v-Src
In addition to unique phosphorylation on tyrosine, an ap-
parent increased phosphorylation of Cx43 on serine was ob-
served in fibroblasts transformed by v-Src (Filson et al.,
1990; Kurata and Lau, 1994). Zhou et al. (1999) suggested
that phosphorylation of Cx43 on serine, possibly through
activation of the MAP kinase pathway, was responsible for
the disruption of GJC by v-Src. This conclusion was based
on the observation that the MEK inhibitor, PD98059,
blocked the disruption of dye transfer between NRK cells af-
ter activation of a temperature-sensitive v-Src by a shift to
the permissive temperature (Zhou et al., 1999). However,
the disruption of dye transfer was not completely blocked by
the MEK inhibitor ( 50%), and the effects of this treat-
ment on MAP kinase activation were not demonstrated.
Treatment with the MEK inhibitor appeared to upregulate
dye transfer in the NRK cells at the restrictive temperature
(Zhou et al., 1999). Since the effects of the inhibitor on
MAP kinase or v-Src kinase activity and on the levels of
pTyr in Cx43 were not shown for the NRK cells after the
shift to the permissive temperature, it is difficult to ascertain
how changing temperature, increasing Src activity, and
changes in MAP kinase activity may have affected Cx43
phosphorylation and impacted GJC.
In our mammalian cell system, treatment of wtS2 cells
with the MEK inhibitor dramatically reduced the level of ac-
tivated MAP kinase to  5% of that of the untreated v-Src
cells (Fig. 7). However, this treatment failed to restore GJC
in the wtS2 cells (Fig. 7). Treating the cells with the MEK
inhibitor for a longer period of time (4 h) also did not in-
crease GJC. The lack of effect of the MEK inhibitor on GJC
and the observation that the double tyrosine Cx43 mutant
was completely resistant to v-Src–induced disruption of
GJC did not support a significant role for MAP kinase in
mediating the disruption of GJC in our cell system. Indeed,
our previous studies in the KO cells expressing wt Cx43
demonstrated that EGF treatment, which induced an  4-
fold greater level of active MAP kinase than was observed in
the wtS2 cells expressing Src (see Fig. 7), initiated only a
modest fall in GJC ( 40%) (Warn-Cramer et al., 1998).824 The Journal of Cell Biology | Volume 154, 2001
This fall in GJC was blocked by pretreatment with the MEK
inhibitor. These results further indicated that MAP kinase
was not a likely candidate for the dramatic disruption of
Cx43 GJC induced by v-Src in these cells.
The reason(s) for the differences in the experimental re-
sults obtained in these different studies is unclear. However,
the data presented in this report have clearly demonstrated
that preventing tyrosine phosphorylation on Cx43 pre-
vented the disruption of GJC in our mammalian cells trans-
formed by v-Src. Although our data did not support a role
for MAP kinase in the disruption of GJC in the v-Src–
expressing cells, we cannot exclude the possibility that MAP
kinase may play a role in other cell systems or under some
experimental conditions.
A model for the interaction of Cx43 with v-Src in the 
disruption of GJC
The results obtained in this study indicated that substitution
of Phe for Tyr at Y247 or Y265 of Cx43 prevented the dis-
ruption of GJC by v-Src in a mammalian cell system. Fur-
thermore, although the MEK inhibitor, PD98059, mark-
edly inhibited the activation of MAP kinase in the v-Src
cells, it did not block the disruption of GJC. Thus, the sim-
plest explanation for these observations is that v-Src disrupts
gap junctions through phosphorylation at the Y247 and
Y265 sites of Cx43 and not through MAP kinase–mediated
serine phosphorylation in these cells.
In our study, the Y265 and Y247 sites both appeared to be
phosphorylated in the mammalian cells that coexpressed wt
Cx43 and constitutively active v-Src. However, the roles for
phosphorylation at the Y247 and Y265 sites of Cx43 in the
regulation of GJC by v-Src appear to be different. Our data
support the hypothesis that phosphorylation of Cx43 at
Y265 by v-Src is required for efficient phosphorylation at
Y247. The phosphorylated Y265 site of Cx43 but not the
Y247 or Y267 sites was shown to be required for stable bind-
ing of Cx43 to the SH2 domain of v-Src in vitro and in vivo
(Kanemitsu et al., 1997). Also, the SH3 domain of v-Src was
shown to bind to the proline-rich motif located at P274-P284
of Cx43 (Kanemitsu et al., 1997).
These observations suggest a working model for how v-Src
interacts with and phosphorylates Cx43 on tyrosine and dis-
rupts GJC (Fig. 8). This model is a modification of the one
proposed by Kanemitsu et al. (1997). The binding of Cx43
to v-Src is initiated by the interaction of the P274-P284 pro-
line-rich region of Cx43 with the SH3 domain of v-Src. This
interaction leads to phosphorylation of Cx43 at the Y265
Figure 8. A model for the interaction of v-Src with Cx43. In this model, the binding of Cx43 to v-Src is dependent upon SH3 and SH2 
domain interactions, which are important for v-Src–induced phosphorylation of Cx43 at the Y265 site and the subsequent phosphorylation at 
the Y247 site, leading to closure of the Cx43 channel (details described in Discussion). PXXP denotes the proline-rich sequence of Cx43 
P274–P284 that interacts with the SH3 domain of v-Src. For simplicity, gap junction channels are represented as cylinders. PM stands for plasma 
membrane.Phosphorylation of Cx43 by Src | Lin et al. 825
site by the kinase domain of v-Src. Phosphorylation at Y265
provides a binding site for the SH2 domain of v-Src, which
stabilizes the binding of Cx43 to v-Src. In our revised model,
the kinase domain of v-Src can now efficiently phosphorylate
Cx43 at the Y247 site, which may represent the key molecu-
lar event triggering the closure of the Cx43 channel by v-Src.
This pattern of sequential SH3 and SH2 domain-binding
reactions in the phosphorylation of Src substrates has been re-
ported previously for the pSer-containing protein p110 (Kan-
ner et al., 1991), the RNA-binding protein p68 (Taylor and
Shalloway, 1994), and the p130
Cas-related protein Sin (Tay-
lor and Shalloway, 1994; Alexandropoulos and Baltimore,
1996). In addition, cytoplasmic tyrosine kinases such as v-Src
have been found to preferentially phosphorylate peptides that
are recognized by their own SH2 domains (Songyang et al.,
1995). Moreover, Src family kinases have been demonstrated
to phosphorylate substrates at multiple Tyr sites by a proces-
sive mechanism (Scott and Miller, 2000), consistent with
that proposed for v-Src and Cx43 in our model.
How does phosphorylation of the Y247 site of Cx43 pro-
mote disruption of GJC? One possibility is that phosphory-
lation of Y247 by v-Src alters the conformation of the Cx43
gap junction channel and leads to closure of the channels.
However, the ability of the CT expressed separately from the
channel-forming portion of Cx43 to participate in Src- or
pH-induced channel closure suggests that this mechanism is
unlikely (Morley et al., 1996; Zhou et al., 1999). Another
possibility is that the addition of a negatively charged phos-
phoryl group at Y247 may permit the cytoplasmic tail of
Cx43 to interact with positively charged amino acids of
Cx43 (for example, residues in the cytoplasmic loop), lead-
ing to blockage of the channel. Finally, phosphorylated
Y247 may represent a potential binding site, which subse-
quently recruits an unknown SH2- or PTB-containing pro-
tein to Cx43 that promotes channel closure. This model, for
Src-induced disruption of GJC by protein–protein interac-
tions and sequential phosphorylation events that lead to the
disruption of GJC, will help guide further studies of the reg-
ulation of GJC by phosphorylation. A challenge for future
studies will be to sort through the various possible mecha-
nisms triggered by tyrosine phosphorylation of Cx43 that
ultimately lead to the closure of the Cx43 channel.
Materials and methods
Cx43 and v-Src constructs
The rat cx43 gene (Beyer et al., 1987) encoding a Phe substitution at the
Y247 site (Y247F or 247F) was prepared from a full-length cx43 gene using
the Chameleon site-directed mutagenesis kit (Stratagene). A full-length
cx43 gene containing the Y265F (or 265F) mutation in a SP64t vector was
provided by Dr. David Paul (Harvard University, Cambridge, Massachu-
setts) and was used to generate the cx43 mutant encoding the double site
mutant (Y247F/Y265F or db) by a recombinant PCR approach (Higuchi,
1989). The mutated cx43 genes were subcloned into the BamHI/EcoRI
sites of the Bluescript (Bssk-) vector and sequenced to confirm the muta-
tions and establish the fidelity of the rest of the gene. The full-length cx43
genes were excised from their original vectors and inserted into the pBABE
retroviral vector (Morgenstern and Land, 1990).
Full-length wt or mutated cx43 genes were used to generate DNAs encod-
ing GST fusion proteins containing the CT (amino acids 236–382) of Cx43
(GST–Cx43CT) by PCR amplification. The PCR products were subcloned
into the BamHI/EcoRI sites of the pGEX-KG expression vector (Loo et al.,
1995), and fidelity of the cx43 genes was confirmed by DNA sequencing.
A pMvsrc plasmid containing a v-src gene was provided by Dr. Tona
Gilmer (Glaxo). The full-length v-src fragment was PCR amplified from the
pMvsrc clone, subcloned into the XhoI/BamHI sites of the pLXSH retroviral
vector (Miller et al., 1993), and sequenced to confirm the authentic v-src
sequences.
Expression, purification, and phosphorylation of GST–Cx43CT 
fusion proteins
GST–Cx43CT fusion proteins were induced in Escherichia coli by treat-
ment with 2 mM IPTG for 2 h at 37 C. Bacterial cells were lysed and the
fusion proteins purified as described (Loo et al., 1995). Purified fusion pro-
teins were quantified by the Bio-Rad Laboratories protein assay and phos-
phorylated by activated Src (Upstate Biotechnology) in a kinase buffer (Loo
et al., 1995) containing 10  Ci of [ -
32P]ATP (NEN Life Science Products)
for 10 min at 30 C. The reaction was stopped by the addition of 4  SDS
sample buffer, and the samples were boiled and resolved by SDS-PAGE.
Generation of Cx43 KO cells reexpressing wt or mutant Cx43 
and coexpressing v-Src
pBABE-cx43 DNAs were transfected into the PE501 packaging cell line
(Miller et al., 1993) using Lipofectamine (GIBCO BRL). Retroviral superna-
tants from the transfected cells were harvested, filtered, and used to infect
the PA317 packaging cell line with 8  g/ml polybrene as described previ-
ously (Martyn et al., 1997; Warn-Cramer et al., 1998). The filtered retrovi-
ral supernatants of the infected PA317 cells were used to infect the Cx43
KO cells (clone 23-3). Infected cells were selected with a medium contain-
ing 6–10  g/ml of puromycin and subcloned by limiting dilution.
The pLvsrcSH or control pLXSH vector DNA was transiently transfected
into PA317 cells. Filtered retroviruses from the transfection were used to in-
fect PE501 cells. Filtered retroviruses from the infected PE501 cells were
used to infect Cx43 KO cells reexpressing wt or mutant Cx43. Stably infected
pLvsrcSH or pLXSH control cells were selected with medium containing 200
U/ml of hygromycin. Single clones were isolated using small squares ( 10
mm
2) of Whatman paper (Domann and Martinez, 1995) and recloned by
limiting dilution. Different pLvsrcSH-infected clones exhibited varying de-
grees of morphological transformation. Two transformed clones from each
set of infections with wt or mutant cx43 and pLvsrcSH were selected for fur-
ther study (Table I). As controls, at least one clone was also selected from
each set of infections with wt or mutant cx43 retroviruses and pLXSH.
Immunofluorescence microscopy of Cx43
The subcellular localization of Cx43 was established in subconfluent cells
grown on glass coverslips. Cells were fixed in 100% methanol at  20 C,
permeabilized with 1% Triton X-100 for 5 min, and incubated with a rab-
bit antiserum directed against peptide 368–382 of Cx43 (Cx43CT368 anti-
serum) at 1:1,000 dilution with 1% BSA in PBS. The Cx43 immune com-
plexes were detected with Alexa Fluor 488–conjugated goat anti–rabbit
antibody (Molecular Probes). The fluorescent images were visualized using
a ZEISS Axioplane Universal microscope equipped with epifluorescence
and captured with a computer using Mocha software (Jandel Scientific).
Cell culture and metabolic 
32Pi labeling
Cells were cultured in DME with 10% FCS (Summit Biotechnology) in a
humidified 5% CO2 incubator at 37 C. In studies using the MEK inhibitor,
PD98059 (New England Biolabs, Inc.), cells were pretreated for 1 h at
37 C with 100  M PD98059 in DMSO or DMSO alone (0.1% vol/vol) as a
control. For studies of Cx43 phosphorylation, confluent monolayers were
metabolically labeled with 
32Pi (NEX-053; NEN Life Science Products; Du-
Pont) at 1 mCi/ml in phosphate-deficient medium with 4% calf serum for
2.5 h at 37 C followed by washing with PBS/160  M Na3VO4/10 mM NaF.
Immunoprecipitation and phosphoamino acid analysis of Cx43
Metabolically labeled or unlabeled cells were solubilized in Ripa buffer
(Crow et al., 1990; Warn-Cramer et al., 1998). The lysates were clarified
by ultracentrifugation at 436,000 g for 20 min at 4 C followed by incuba-
tion with the Cx43CT368 antiserum under conditions of antigen excess.
Immune complexes were precipitated with activated protein A–Staphylo-
coccus aureus and resolved by SDS-PAGE. The gels were dried and auto-
radiographed using Eastman Kodak Co. X-OMAT XAR-5 films at  70 C.
For phosphoamino acid analysis, 
32P-labeled proteins were electrotrans-
ferred from the unfixed gel to an Immobilon-P membrane (Millipore).
Membrane pieces containing the desired Cx43 protein bands were excised
and acid hydrolyzed as previously described (Loo et al., 1995). Hydro-
lyzed samples were mixed with nonradioactive phosphoamino standards
(pSer, phosophpthreonine [pThr], and pTyr) and separated on TLC plates at
pH 1.9 and 3.5 (Kamps and Sefton, 1989; Crow et al., 1992; Warn-Cramer826 The Journal of Cell Biology | Volume 154, 2001
et al., 2000). The plates were exposed to Biomax ML films with Biomax in-
tensifying screens (Eastman Kodak Co.) at  70 C. The relative amounts of
pTyr of Cx43 were quantified by measuring the density times the area of
the pTyr spots using the Quantity One software provided with the Fluor-S
MultiImager (Bio-Rad Laboratories).
Two-dimensional phosphotryptic peptide analysis of
GST–Cx43CT fusion proteins phosphorylated by activated Src 
and Cx43 isolated from v-Src–expressing cells
GST–Cx43CT phosphorylated by activated Src in vitro with [ -
32P]ATP or
full-length Cx43 isolated from 
32P-labeled cells expressing v-Src was re-
solved by SDS-PAGE and autoradiographed. Gel pieces containing the
phosphorylated Cx43 were excised from the wet unfixed gel and finely
ground. Phosphorylated Cx43 was eluted from the gel pieces as described
(Boyle et al., 1991; Warn-Cramer et al., 2000), oxidized with performic
acid, lyophilized to dryness, and digested overnight at 37 C with N-tosyl-
L-phenylalanine chloromethylketone–treated trypsin (Worthington). The
resulting phosphotryptic peptides were resolved on TLC plates by electro-
phoresis in pH 1.9 buffer for 1 h at 1000 V followed by ascending chroma-
tography in the second dimension in an isobutyric acid buffer. After air
drying, the plates were exposed to Eastman Kodak Co. X-Omat XAR-5 film
with the aid of an intensifying screen at  70 C.
In vitro analysis of the protein kinase activity of v-Src
Cells were lysed in Ripa buffer, clarified, and immunoprecipitated using
tumor-bearing rabbit (TBR) serum 6-1-4 obtained from rabbits bearing
Rous sarcoma virus–induced tumors (Brugge and Erikson, 1977). The IgG
heavy chain of the TBR serum served as a substrate for active v-Src in an
immune complex kinase assay (Collett et al., 1980). Immunoprecipitated
v-Src was assayed in vitro in a 20- l reaction volume-containing kinase
buffer (Loo et al., 1995) with 10  Ci of [ -
32P]ATP for 10 min at room tem-
perature. The reaction was stopped by the addition of 20  l of 2  SDS
sample buffer and boiling. Proteins were resolved by SDS-PAGE, and the
gels were dried and autoradiographed using Eastman Kodak Co. X-Omat
XAR-5 films.
Immunoblotting analysis of Cx43 and activated MAP kinase
Cx43 expression was measured by immunoblotting cell lysates obtained
from confluent monolayers. Cells were harvested, lysed in lysis buffer (Loo
et al., 1999), and protein concentrations were determined by the Bradford
method (Bio-Rad Laboratories). Samples containing equal amounts of pro-
tein were resolved by SDS-PAGE. Cx43 was detected with Cx43CT368 an-
tiserum using the ECL immunoblotting kit (Amersham Pharmacia Biotech).
To quantify the relative levels of pTyr, Cx43 was immunoprecipitated
from lysates of cells grown to confluence on 60-mm culture dishes using
equal amounts of Cx43CT368 antiserum under conditions of antigen ex-
cess. Samples were separated by SDS-PAGE and transferred to Immobilon-
P membranes (Millipore). pTyr was detected with an anti-pTyr monoclonal
antibody (PY99) (Santa Cruz Biotechnology, Inc.) using the ECL-plus im-
munoblotting kit (Amersham Pharmacia Biotech) and Eastman Kodak Co.
X-Omat XAR-5 films. The films were scanned using a MultiImager, and the
relative amounts of pTyr of Cx43 were quantified as described for the
phosphoamino acid analysis.
To examine MAP kinase activation, v-Src–expressing cells were treated
with either 100  M MEK inhibitor, PD98059, in DMSO or DMSO alone
for 1 h or 4 h at 37 C. Cx43 KO cells reexpressing wt Cx43 were treated
with EGF at 100 ng/ml for 2 min as a positive control for activated MAP ki-
nase (Warn-Cramer et al., 1998). Cells were harvested, lysed, and equal
amounts of protein were resolved by SDS-PAGE and then electrotrans-
ferred to Immobilon-P membranes. Activated MAP kinase was detected
with a rabbit antibody specific for the phosphorylated activated form of
MAP kinase (Promega) using the ECL-plus immunoblotting kit and Eastman
Kodak Co. X-Omat XAR-5 films. After the detection of activated MAP ki-
nase, the membranes were stripped as described (ECL immunoblotting kit)
and reblotted with an antibody recognizing all isoforms of p42 MAP kinase
(Santa Cruz Biotechnology, Inc.). The relative amounts of MAP kinase
were quantified as described for the pTyr immunoblotting. The ratio of the
amounts of active MAP kinase to all isoforms of MAP kinase in the wtS2
cells without MEK inhibitor treatment was set to 100%. The percentages of
the other samples were normalized accordingly.
Measurement of GJC
Cells were grown to confluence on 35-mm culture dishes. Single cells
were microinjected with a glass micropipette (Eppendorf) containing the
fluorescent dye Lucifer yellow (10%, wt/vol) using an Eppendorf Transjec-
tor 5246 and an Eppendorf micromanipulator that relies on pressure for
dye injection. The fluorescent images were visualized with a ZEISS phase–
contrast inverted microscope equipped with epifluorescence. The number
of adjacent cells that became fluorescent was counted 1 min after microin-
jection. GJC values were determined by the microinjection of approxi-
mately six cells/plate from an average of six plates/sample in studies
carried out on at least two different days. P values were determined by
two-tailed Student’s t tests. Fluorescent images from single cell microinjec-
tions were captured 4–6 min after microinjection using the Mocha soft-
ware.
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